Studies related to Blood Pressure and Vanadium

Oral Vanadyl Sulfate Improves Hepatic And Peripheral Insulin Sensitivity In Patients With Non-insulin-dependent Diabetes Mellitus

Effect None
Trial Design Non-randomized controlled trial
Trial Length 2-4 Weeks
Number of Subjects 6
Sex Both Genders
Age Range 45-64
Body Types Overweight
Notes for this study:
6 persons with type II diabetes subject to Vanadium treatment for 3 weeks at 100mg daily improved glucose tolerance and insulin sensitivity in response to glucose by enhancing the actions of insulin; these persisted for 2 weeks after cessation of vanadium.

A trend to reduce triglycerides was noted, but failed to be significant.